|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| OTC Pharmaceuticals in the Netherlands |
|
|
|
|
€ 200,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Septembre 2008 |
Taille du document : |
33 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Chinese Markets for OTC Drugs 220 pages | Février 2002 |
China's demand for OTC drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trend |
2 835,00 €
|
| |
| |
Poland OTC Pharmaceuticals 2004 11 pages | Juillet 2004 |
Snapdata's Poland OTC Pharmaceuticals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the Polish OTC pharmaceuti |
240,00 €
|
| |
| |
US Weight Control 2004 12 pages | Novembre 2004 |
Snapdata's US Weight Control 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US weight control market, and c |
240,00 €
|
| |
| |
OTC Vitamins and Dietary Supplements in Germany 10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Vitamins and Dietary Supplements in Germany' Major Market Profile report offers an introduction to the market. It is c. 10 pages long and provides a top line ov |
198,00 €
|
| |
| |
US Nasal Products 2004 13 pages | Juillet 2004 |
Snapdata's US Nasal Products 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US nasal product market, and co |
240,00 €
|
| |
| |
The Pharmaceutical OTC Market to 2010 130 pages | Février 1999 |
Survey : Datamonitor's survey identifies the role that the OTC market plays within the healthcare environment and the current and future dynamics of the industry in terms of OTC therapies and in |
795,00 €
|
| |
| |
Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies 146 pages | Janvier 2005 |
Pressure on the pharmaceutical industry to deliver productivity, strong generics market growth as well as an unfavorable legislative environment have caused pharmaceutical companies to reassess the mo |
1 520,00 €
|
| |
| |
US Analgesics 2004 14 pages | Juillet 2004 |
Snapdata's US Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US analgesic market, and covers non |
240,00 €
|
| |
| |
US Family Planning 2004 12 pages | Novembre 2004 |
Snapdata's US Family Planning 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US family planning market, and |
240,00 €
|
| |
| |
Chinese Markets for Drug Delivery Systems 210 pages | Mai 2004 |
China's demand for drug delivery systems has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's ec |
2 835,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Pharmaceuticals in the Netherlands |
|
|
Datamonitor's OTC Pharmaceuticals in the Netherlands industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Scope * Contains an executive summary and data on value, volume and/or segmentation
* Provides textual analysis of the industry’s recent performance and future prospects
* Incorporates in-depth five forces competitive environment analysis and scorecards * Includes a five-year forecast of the industry
* The leading companies are profiled with supporting key financial metrics * Supported by the key macroeconomic and demographic data affecting the market Highlights * Detailed information is included on market size, measured by both value and volume * Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape
* Market shares are covered by manufacturer and/or brand
* Also features market breakdown by distribution channel Why you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level research
Market Definition
The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates.
Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.
|
|
TABLE OF CONTENTS EXECUTIVE SUMMARY 3 CHAPTER 1 Market Overview 7 1.1 Market Definition 7 1.2 Research Highlights 7 1.3 Market Analysis 8 CHAPTER 2 Market Value 9 CHAPTER 3 Market Segmentation I 10 CHAPTER 4 Market Segmentation II 11 CHAPTER 5 Market Share 12 CHAPTER 6 Five Forces Analysis 13 6.1 Summary 13 6.2 Buyer Power 14 6.3 Supplier Power 15 6.4 New Entrants 16 6.5 Substitutes 18 6.6 Rivalry 19 CHAPTER 7 Leading Companies 20 7.1 Bayer AG 20 7.2 Pfizer Inc 23 7.3 Procter & Gamble Company, The 25 CHAPTER 8 Distribution 28 CHAPTER 9 Market Forecasts 29 9.1 Market Value Forecast 29 CHAPTER 10 Macroeconomic Indicators 30 CHAPTER 11 Appendix 32 11.1 Methodology 32 11.2 Industry Associations 33 11.3 Related Datamonitor Research 33 LIST OF TABLES Table 1: Netherlands OTC Pharmaceuticals Market Value: $ million, 2003-2007 9 Table 2: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 10 Table 3: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 11 Table 4: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2007 12 Table 5: Key Facts: Bayer AG 20 Table 6: Key Financials: Bayer AG 22 Table 7: Key Facts: Pfizer Inc 23 Table 8: Key Financials: Pfizer Inc 24 Table 9: Key Facts: Procter & Gamble Company, The 25 Table 10: Key Financials: Procter & Gamble Company, The 27 Table 11: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2007 28 Table 12: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012 29 Table 13: Netherlands Size of Population (million) , 2003-2007 30 Table 14: Netherlands GDP (Constant 2000 Prices, $ billion), 2003-2007 30 Table 15: Netherlands Inflation, 2003-2007 30 Table 16: Netherlands Exchange Rate, 2003 31
|
|
|
PPLSEN
|
|
|
|
|